Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $3.984B Est

Benzinga Newsdesk www.benzinga.com Negative 79.9%

Neg 79.9% Neu 0% Pos 0%

Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $3.984 billion estimate.